Mu-opioid receptor and delta-opioid receptor differentially regulate microglial inflammatory response to control proopiomelanocortin neuronal apoptosis in the hypothalamus: effects of neonatal alcohol
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-2094
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Mu-opioid receptor and delta-opioid receptor differentially regulate microglial inflammatory response to control proopiomelanocortin neuronal apoptosis in the hypothalamus: effects of neonatal alcohol ; volume:14 ; number:1 ; day:14 ; month:4 ; year:2017 ; pages:1-19 ; date:12.2017
Journal of neuroinflammation ; 14, Heft 1 (14.4.2017), 1-19, 12.2017
- Schlagwort
-
Immunologie
Immunsystem
Lymphozyt
Leukozyt
Immunität
Resistenz
Immunchemie
- Urheber
-
Shrivastava, Pallavi
- Beteiligte Personen und Organisationen
-
Cabrera, Miguel A.
Chastain, Lucy G.
Boyadjieva, Nadka I.
Jabbar, Shaima
Franklin, Tina
Sarkar, Dipak K.
SpringerLink (Online service)
- DOI
-
10.1186/s12974-017-0844-3
- URN
-
urn:nbn:de:1111-201704305110
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Shrivastava, Pallavi
- Cabrera, Miguel A.
- Chastain, Lucy G.
- Boyadjieva, Nadka I.
- Jabbar, Shaima
- Franklin, Tina
- Sarkar, Dipak K.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Untangling the complexity of opioid receptor function
Heteromerization of μ-opioid receptor and cholecystokinin B receptor through the third transmembrane domain of the μ-opioid receptor contributes to the anti-opioid effects of cholecystokinin octapeptide
Opioid receptor efficacy during normal and pathological conditions
Opioid receptor oligomerization study through fluorescent selective ligands
Opioid receptor efficacy during normal and pathological conditions
Molecular Signalling Mechanisms at the µ-Opioid Receptor
Gαi-derived peptide binds the µ-opioid receptor
Mechanisms and consequences of µ-opioid receptor dimerization
Label-free integrative pharmacology on-target of opioid ligands at the opioid receptor family
Mu-opioid receptor gene variant OPRM1 118A>G : a genetic modulator of opioid effects
Regulation of µ-opioid receptor function by pH
Photochromic Fentanyl Derivatives for Controlled μ‐Opioid Receptor Activation
Untangling the complexity of opioid receptor function
Heteromerization of μ-opioid receptor and cholecystokinin B receptor through the third transmembrane domain of the μ-opioid receptor contributes to the anti-opioid effects of cholecystokinin octapeptide
Opioid receptor efficacy during normal and pathological conditions
Opioid receptor oligomerization study through fluorescent selective ligands
Opioid receptor efficacy during normal and pathological conditions
Molecular Signalling Mechanisms at the µ-Opioid Receptor
Gαi-derived peptide binds the µ-opioid receptor
Mechanisms and consequences of µ-opioid receptor dimerization
Label-free integrative pharmacology on-target of opioid ligands at the opioid receptor family
Mu-opioid receptor gene variant OPRM1 118A>G : a genetic modulator of opioid effects
Regulation of µ-opioid receptor function by pH
Photochromic Fentanyl Derivatives for Controlled μ‐Opioid Receptor Activation
Untangling the complexity of opioid receptor function
Heteromerization of μ-opioid receptor and cholecystokinin B receptor through the third transmembrane domain of the μ-opioid receptor contributes to the anti-opioid effects of cholecystokinin octapeptide
Opioid receptor efficacy during normal and pathological conditions
Opioid receptor oligomerization study through fluorescent selective ligands
Opioid receptor efficacy during normal and pathological conditions
Molecular Signalling Mechanisms at the µ-Opioid Receptor
Gαi-derived peptide binds the µ-opioid receptor
Mechanisms and consequences of µ-opioid receptor dimerization
Label-free integrative pharmacology on-target of opioid ligands at the opioid receptor family
Mu-opioid receptor gene variant OPRM1 118A>G : a genetic modulator of opioid effects
Regulation of µ-opioid receptor function by pH